Vaccines and lockdown easing pushes IG corporate market into new phase

By Mike Turner
21 May 2020

Governments around the world have begun easing coronavirus lockdowns and progress is being made on vaccines, but Europe’s high grade corporate bankers are still unsure about the future of the market.

UK drug maker AstraZeneca was the latest company to bring some cheer to markets this week when, on Thursday, it said that it would begin delivering at least 400m doses of a Covid-19 vaccine in September. The vaccine has not yet been proven. At the start of the ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access:

Or sign up for a trial to gain full access to the entire site for a limited period.

Free Trial

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: or find out more online here.